Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar-Apr;43(2):289-303.
doi: 10.1590/S1677-5538.IBJU.2016.0047.

Research prioritization of men's health and urologic diseases

Affiliations

Research prioritization of men's health and urologic diseases

Tyler Okland et al. Int Braz J Urol. 2017 Mar-Apr.

Abstract

Objectives: We sought to determine whether disease representation in the Cochrane Database of Systematic Reviews (CDSR) reflects disease burden, measured by the Global Burden of Disease (GBD) Study as disability-adjusted life-years (DALYs).

Materials and methods: Two investigators performed independent assessment of ten men's health and urologic diseases (MHUDs) in CDSR for systematic review and protocol representation, which were compared with percentage of total 2010 DALYs for the ten conditions. Data were analyzed for correlation using Spearman rank analysis.

Results: Nine of ten MHUDs were represented by at least one CDSR review. There was a poor and statistically insignificant positive correlation between CDSR representation and disease burden (rho = 0.42, p = 0.23). CDSR representation was aligned with disease burden for three conditions, greater than disease burden for one condition, and less than disease burden for six conditions.

Conclusions: These results yield high-quality estimates to inform future research prioritization for MHUDs. While prioritization processes are complex and multi-faceted, disease burden should be strongly considered. Awareness of research priority setting has the potential to minimize research disparities on a global scale.

Keywords: Infertility, Male; Men’s Health; Urologic Diseases.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

None declared.

Figures

Figure 1
Figure 1. Square pie chart representing percent of total DALY for ten men’s health and urologic diseases; area of each square/rectangle represents percentage of total burden.
Figure 2
Figure 2. Comparison of men’s health and urologic disease representation in the Cochrane Database of Systematic Reviews with percent of 2010 DALYs from 291 conditions studied by GBD 2010.

References

    1. Fleurence RL. Setting priorities for research: a practical application of ‘payback’ and expected value of information. Health Econ. 2007;16:1345–1357. - PubMed
    1. Nasser M, Welch V. Prioritization of systematic reviews leads prioritization of research gaps and needs. J Clin Epidemiol. 2013;66:522–523. - PubMed
    1. Shiffman J. Knowledge, moral claims and the exercise of power in global health. Int J Health Policy Manag. 2014;3:297–299. - PMC - PubMed
    1. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380:2063–2066. - PubMed
    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128. Erratum in: Lancet. 2013;381:628. - PMC - PubMed